18 results
DRS/A
EX-10.7
SQZB
SQZ Biotechnologies Co
28 Aug 20
Draft registration statement (amended)
12:00am
Election Notice
Control
Cover
Development Costs
Effective Date
EU
Expert
FBMC
FDA
FDCA
Field
Filing
First Commercial Sale
FTE Rate
GAAP
GCP
Generic Product … Union and all its then-current member countries.
1.33 Expert
The term “Expert” shall mean a person reasonably acceptable to both Parties having
S-1
EX-10.7
SQZB
SQZ Biotechnologies Co
9 Oct 20
IPO registration
4:59pm
Election Notice
Control
Cover
Development Costs
Effective Date
EU
Expert
FBMC
FDA
FDCA
Field
Filing
First Commercial Sale
FTE Rate
GAAP
GCP
Generic Product … Union and all its then-current member countries.
1.33 Expert
The term “Expert” shall mean a person reasonably acceptable to both Parties having
DEF 14A
SQZB
SQZ Biotechnologies Co
26 Apr 21
Definitive proxy
5:00pm
, on a consulting, project and expert witness basis. Before that, from March 2011 to November 2016, Mr. Knopf served as Senior Vice President and General Counsel … . is an “audit committee financial expert” as defined by applicable SEC rules and has the requisite financial sophistication as defined under the applicable
PRE 14A
sgif668ts27 r1
10 Apr 23
Preliminary proxy
4:31pm
424B4
jhaxpfxx
12 Feb 21
Prospectus supplement with pricing info
5:10pm
424B4
eix5upjn
30 Oct 20
Prospectus supplement with pricing info
4:54pm
DRS
0rp5e72w3o
1 Feb 21
Draft registration statement
12:00am
S-1
dlbgqgd 8yip
9 Oct 20
IPO registration
4:59pm
DRS/A
vgo9d egxewvfjipo
28 Aug 20
Draft registration statement (amended)
12:00am
DRS
gyq5hew0robr7jg 8s44
21 Jul 20
Draft registration statement
12:00am
DRS/A
d38ujh7tw6e4c9
25 Sep 20
Draft registration statement (amended)
12:00am
10-K
hanpp
18 Mar 21
Annual report
6:31am
- Prev
- 1
- Next